2-(2-Phenylethyl)-1,3-thiazole-4-carboxylic acid, 97%, 1g

(1R,2R)-(+)-1,2-Diphenylethylenediamine, 98.0%, 25g

4-aminophénol, min.98%, pour la synthèse, 500 g, emballage en verre

(2E)-3-(2-methoxyphenyl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

5-Fluorobenzo-[2,1,3]-thiadiazole, 95.0%, 250mg

tert-Butyl (4-(4-amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate, 95%, 100mg

6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-5-one, 95.0%, 250mg

(4-Fluoro-3-(2,2,2-trifluoroethoxy)phenyl)boronic acid, 95.0%, 5g

TERT-BUTYL (2-(1H-1,2,3-TRIAZOL-1-YL)ETHYL)CARBAMATE, 95.0%, 500mg

3-Bromo-2-chloro-5-fluoropyridine, 95.0%, 10g

tert-butyl 5-(trifluoromethyl)-1H-indole-1-carboxylate, 95.0%, 250mg

1-METHYL-4-OXO-CYCLOHEXANECARBONITRILE, 95.0%, 500mg

Pointes de pipettes UNIVERSELLES 100–1200 μl, Recharge, 960 pièces, Non stérile, incolore, 960 pièces